Fig. 4.
Patient with metastatic pancreatic carcinoma isolated to the liver. Pre-RFA contrast enhanced axial CT slice (a) shows detailed morphology with 4 possible targets (arrows) for treatment. PET (b) shows abnormal FDG uptake in 2 anterior liver lesions. Intermodality PET/CT fusion (c) localizes active lesions (crosshairs). Volume rendering (d) visualizes metabolic activity with 3 dimensional details